Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-292546 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
10,000
Total Value
$415,797.77
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 30, 2026 | Sale | 1,900 | $40.09 | $76,173.66 | 158,014 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 30, 2026 | Sale | 3,792 | $41.39 | $156,963.77 | 154,222 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 30, 2026 | Sale | 3,308 | $42.17 | $139,505.64 | 150,914 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 30, 2026 | Sale | 1,000 | $43.15 | $43,154.70 | 149,914 | Direct | โ | View Details |